Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

AI Analyst Top Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Cartesian Therapeutics (RNAC)

NASDAQ:RNAC

US Market

RNAC

Cartesian Therapeutics

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

Cartesian Therapeutics (RNAC) Stock News & Sentiment

1,115 Followers

Promising Potential of Cartesian Therapeutics: Buy Rating Backed by Phase III AURORA Trial and Descartes-08 Performance

Ratings

Promising Potential of Cartesian Therapeutics: Buy Rating Backed by Phase III AURORA Trial and Descartes-08 Performance

5d ago

Promising Developments and Strong Financial Health Support Buy Rating for Cartesian Therapeutics

Ratings

Promising Developments and Strong Financial Health Support Buy Rating for Cartesian Therapeutics

8d ago

Cartesian Therapeutics Reports Positive Q2 2025 Earnings

Company Announcements

Cartesian Therapeutics Reports Positive Q2 2025 Earnings

8d ago

Optimistic Buy Rating for Cartesian Therapeutics Driven by Promising Clinical Pipeline and Strong Financial Health

Ratings

Optimistic Buy Rating for Cartesian Therapeutics Driven by Promising Clinical Pipeline and Strong Financial Health

9d ago

Cartesian Therapeutics Advances mRNA CAR T-cell Therapy for Myasthenia Gravis

Company Announcements

Cartesian Therapeutics Advances mRNA CAR T-cell Therapy for Myasthenia Gravis

1M ago

Cartesian Therapeutics Holds Annual Stockholders Meeting

Company Announcements

Cartesian Therapeutics Holds Annual Stockholders Meeting

2M ago

Promising Outlook for Cartesian Therapeutics: Buy Rating Backed by Advancements in Descartes-08 Trials and Strong Financial Projections

Ratings

Promising Outlook for Cartesian Therapeutics: Buy Rating Backed by Advancements in Descartes-08 Trials and Strong Financial Projections

3M ago

More RNAC News >

RNAC News on the Web

2025-08-07

Mizuho Securities Reaffirms Their Buy Rating on Cartesian Therapeutics (RNAC)

TipRanks News

Neutral

2025-08-07

Why Cartesian Therapeutics, Inc.’s (RNAC) Stock Is Down 5.41%

AAII

Neutral

2025-07-28

Why Cartesian Therapeutics, Inc.’s (RNAC) Stock Is Up 5.48%

AAII

Neutral

2025-07-24

Cartesian Therapeutics, Inc. (RNAC) Moves 9.9% Higher: Will This Strength Last?

Zacks

Neutral

2025-07-23

Why Cartesian Therapeutics, Inc.’s (RNAC) Stock Is Up 7.46%

AAII

Neutral

2025-07-21

Why Cartesian Therapeutics, Inc.’s (RNAC) Stock Is Up 5.07%

AAII

Neutral

2025-07-09

Why Cartesian Therapeutics, Inc.’s (RNAC) Stock Is Up 17.70%

AAII

Neutral

2025-07-02

Why Cartesian Therapeutics, Inc.’s (RNAC) Stock Is Up 5.74%

AAII

Neutral

News Score - Last 7 Days

Neutral

RNAC

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week59%

Sector Average55%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RNAC’s Media Buzz Sentiment?

Currently, no data Available

What is RNAC’s weekly average amount of articles?

Currently, no data Available

What is RNAC’s News Sentiment?

59% of articles about RNAC were positive this week, compared to its sector average of 55%.

Healthcare Stocks that are Trending in the News

IXIIXICO plc

VREXVarex Imaging

KMDAKamada

OXBDFOxford BioMedica

BLFSBioLife Solutions

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing